Physician profile
Daniel B Schmid
NPI 1386844660
$2,213.51
in general payments reported to CMS, 2019-2025
11 companies · $1,651 in 2025
The $1,651 reported for 2025 was more than what 82% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $111 · 2020: $31.99 · 2021: $48.87 · 2022: $87.56 · 2023: $180 · 2024: $103 · 2025: $1,651.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,050 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $750 · Travel and Lodging: $134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,050.47 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $750.00 |
| Travel and Lodging | $134.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $1,101.00 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander, Mentor Cpx 2 Breast Tissue Expander |
| Abbvie INC. | $403.30 | 2023-2025 | Alloderm |
| Musculoskeletal Transplant Foundation INC. | $336.33 | 2025 | |
| Baxter Healthcare | $102.40 | 2024-2025 | Perclot |
| Allergan, INC. | $90.55 | 2019-2022 | |
| Tela Bio, INC. | $56.42 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Revance Therapeutics, INC. | $48.44 | 2024-2025 | Daxxify |
| Polynovo North America LLC | $24.13 | 2022 | |
| Davol INC. | $21.39 | 2025 | Galaflex Lite |
| Axogen | $17.15 | 2025 | |
| Kci USA, INC. | $12.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Schmid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.